Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?

European Heart Journal

18 January 2019
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease Pharmacology and Pharmacotherapy

Abstract

Abstract

Contributors